Nabriva Therapeutics AG

  • Founded in 2006
  • Employees: 52
  • Financial data: €243M Market Cap (on 13/02/2017)

Nabriva.com

Description :

Nabriva Therapeutics is a company focused on developing a new class of antibiotics, pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resistant pathogens.

Headquarters :

Leberstrasse 20 1110 Vienna

Send this to friend